Characterization of ARTS-011, a potent and selective TYK2 inhibitor for the treatment of inflammatory disease
Liang, Jiaqi, Liu, Yiting, Zhang, Xiaobin, Zhang, Tao, Liu, Xipan, Fu, Jia, Cheng, Dai, Xiong, Wen, Ding, Peter, Zhu, Cong, Li, Fang, Chen, Yaoyu
Published in The Journal of immunology (1950) (01.05.2022)
Published in The Journal of immunology (1950) (01.05.2022)
Get full text
Journal Article
Determination of parvovirus antibodies in canine serum using magnetic bead-based chemiluminescence immunoassay
Chen, Cuicui, Guo, Xiaoxiao, Liang, Huankun, Ning, Bo, Li, Jiexing, Zhong, Shuhai, Liu, Xipan, Li, Laiqing
Published in Biotechnology and applied biochemistry (01.07.2019)
Published in Biotechnology and applied biochemistry (01.07.2019)
Get more information
Journal Article
Abstract B173: The anti-tumor activity of CDK2 inhibition alone or in combination with other anti-cancer agents in human cancers
Chen, Yaoyu, Chen, Jinhong, Guo, Yali, Pang, Wei, Zhou, Tingru, Liu, Xipan, Schomer, Nathan, Li, Fang, Liang, Jiaqi, Sheng, Qing
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract A022: CDK2 inhibition demonstrates synthetic lethality in SCLC through apoptotic induction
Schomer, Nathan, Chen, Jinhong, Pang, Wei, Zhou, Tingru, Liu, Xipan, Liang, Wenhen, Guo, Yali, Cheng, Dai, Li, Fang, Liang, Jiaqi, Chen, Yaoyu, Sheng, Qing
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract 2568: ARTS-021 is a potent and selective CDK2 inhibitor that demonstrates anti-cancer activity in preclinical cancer models with CCNE1 amplification
Liang, jiaqi, Cheng, Dai, Guo, Yali, zhang, xiaobin, Liu, Xipan, Fu, Jia, Ding, Qiang, Xiong, Wen, Li, Fang, Chen, Yaoyu, Sheng, Qing
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
The effect of high-dose lovastatin therapy on patients with acute cerebral infarction
Guo, Xiaoxiao, Chen, Cuicui, Ye, Jingwen, Li, Kangyan, Li, Jiexing, Cheng, Chengwu, Liang, Huankun, Liu, Xipan, Zhong, Shuhai, Lai, Hongrui, Huang, Xiaoting, Yang, Qinglan, Zhang2, Licheng, Li, Laiqing
Published in Gastroenterology, Hepatology and Endoscopy (2017)
Published in Gastroenterology, Hepatology and Endoscopy (2017)
Get full text
Journal Article
METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF
CAO, Lihua, CHENG, Senping, LIU, Xin, LI, Xiaoling, LIU, Xipan, DENG, Feihuang
Year of Publication 06.06.2024
Get full text
Year of Publication 06.06.2024
Patent
METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF
CAO, Lihua, CHENG, Senping, LIU, Xin, LI, Xiaoling, LIU, Xipan, DENG, Feihuang
Year of Publication 24.01.2024
Get full text
Year of Publication 24.01.2024
Patent
METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF
CAO, Lihua, CHENG, Senping, LIU, Xin, LI, Xiaoling, LIU, Xipan, DENG, Feihuang
Year of Publication 22.09.2022
Get full text
Year of Publication 22.09.2022
Patent